IFN-beta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell

Insights

Recombinant human interferon-beta (rHuIFN-beta) triggers apoptosis in specific colon cancer cells. This occurs via mitochondrial damage and caspase activation, independent of p53 or Fas/FasL pathways.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Human interferon-beta (HuIFN-beta) exhibits variable efficacy in inhibiting colon cancer cell growth.
  • Colon cancer cell lines display differential responses to HuIFN-beta, influenced by p53 mutation status and tumor grade.

Purpose of the Study:

  • To investigate the mechanisms by which recombinant human interferon-beta (rHuIFN-beta) induces apoptosis in p53-mutant colon cancer cell lines.
  • To elucidate the role of p53, Fas/FasL pathway, and mitochondrial integrity in HuIFN-beta-mediated apoptosis.

Main Methods:

  • In vitro treatment of human colon cancer cell lines (COH, CC-M2, HT-29) with varying concentrations of HuIFN-beta.
  • Analysis of apoptosis, cell cycle, Fas/FasL protein levels, mitochondrial membrane potential, and caspase activation (caspase-9, -8, -3).
  • Use of specific inhibitors and blocking antibodies to dissect apoptotic pathways.

Main Results:

  • HuIFN-beta induced apoptosis in p53-mutant COH and CC-M2 cells, but only cell cycle arrest in HT-29 cells.
  • Apoptosis in COH and CC-M2 cells involved increased Fas/FasL, altered mitochondrial potential, and caspase cascade activation.
  • Fas/FasL blocking agents did not prevent apoptosis, while caspase inhibitors blocked DNA fragmentation but not mitochondrial changes.
  • Mitochondria-stabilizing reagents abrogated HuIFN-beta-induced apoptosis and caspase activation.

Conclusions:

  • HuIFN-beta induces apoptosis in susceptible colon cancer cells primarily through mitochondrial membrane destabilization and subsequent caspase cascade activation.
  • The apoptotic mechanism is independent of the p53 status and Fas/FasL signaling pathway in these cell lines.
  • Targeting mitochondrial pathways may enhance HuIFN-beta's therapeutic potential in colon cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.